| Symbol | Company | Owner | Relationship | Date | Transaction | Cost | # Shares | Value ($) | Total Shares | Filing | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ATRA | Atara Biotherapeutics, Inc. | Haqq Christopher | EVP, R&D & Chief Scientific Of | Feb 15, 2019 | Sale | $39.59 | 775 | 30,682 | 271,943 | Feb 19, 2019, 05:08 PM | |
| ATRA | Atara Biotherapeutics, Inc. | Haqq Christopher | EVP, R&D & Chief Scientific Of | Feb 11, 2019 | Sale | $38.55 | 13,975 | 538,736 | 272,718 | Feb 11, 2019, 07:10 PM | |
| ATRA | Atara Biotherapeutics, Inc. | Haqq Christopher | EVP, R&D & Chief Scientific Of | Feb 06, 2019 | Option Exercise | $38.60 | 13,887 | 536,088 | 282,903 | Feb 08, 2019, 04:28 PM | |
| ATRA | Atara Biotherapeutics, Inc. | Haqq Christopher | EVP, R&D & Chief Scientific Of | Nov 15, 2018 | Sale | $33.81 | 775 | 26,203 | 285,580 | Nov 15, 2018, 04:53 PM | |
| ATRA | Atara Biotherapeutics, Inc. | Haqq Christopher | EVP, R&D & Chief Scientific Of | Sep 26, 2018 | Sale | $43.08 | 13,500 | 581,580 | 286,355 | Sep 27, 2018, 04:56 PM | |
| ATRA | Atara Biotherapeutics, Inc. | Haqq Christopher | EVP, R&D & Chief Scientific Of | Sep 24, 2018 | Sale | $39.91 | 18,000 | 718,426 | 317,286 | Sep 25, 2018, 05:02 PM | |
| ATRA | Atara Biotherapeutics, Inc. | Haqq Christopher | EVP, R&D & Chief Scientific Of | Sep 25, 2018 | Sale | $40.51 | 13,500 | 546,905 | 303,355 | Sep 25, 2018, 05:02 PM | |
| ATRA | Atara Biotherapeutics, Inc. | Haqq Christopher | EVP, R&D & Chief Scientific Of | Aug 15, 2018 | Sale | $37.54 | 775 | 29,094 | 331,355 | Aug 16, 2018, 05:12 PM | |
| ATRA | Atara Biotherapeutics, Inc. | Haqq Christopher | EVP, R&D & Chief Scientific Of | May 15, 2018 | Option Exercise | $28.41 | 50,775 | 1,442,480 | 357,905 | May 16, 2018, 08:37 PM | |
| ATRA | Atara Biotherapeutics, Inc. | Haqq Christopher | EVP, R&D & Chief Scientific Of | Mar 26, 2018 | Sale | $39.79 | 18,327 | 729,264 | 334,005 | Mar 27, 2018, 04:16 PM | |
| ATRA | Atara Biotherapeutics, Inc. | Haqq Christopher | EVP, R&D & Chief Scientific Of | Feb 09, 2018 | Option Exercise | $41.70 | 4,925 | 205,373 | 350,679 | Feb 12, 2018, 08:55 PM | |
| ATRA | Atara Biotherapeutics, Inc. | Haqq Christopher | EVP, R&D & Chief Scientific Of | Feb 06, 2018 | Option Exercise | $35.80 | 4,426 | 158,451 | 355,604 | Feb 08, 2018, 05:46 PM | |
| ATRA | Atara Biotherapeutics, Inc. | Haqq Christopher | EVP, R&D & Chief Scientific Of | Nov 15, 2017 | Sale | $13.36 | 1,604 | 21,429 | 342,530 | Nov 17, 2017, 06:27 PM | |
| ATRA | Atara Biotherapeutics, Inc. | Haqq Christopher | EVP, R&D & Chief Scientific Of | Oct 16, 2017 | Sale | $14.35 | 6,000 | 86,100 | 343,305 | Oct 17, 2017, 04:46 PM | |
| ATRA | Atara Biotherapeutics, Inc. | Haqq Christopher | EVP, R&D & Chief Scientific Of | Sep 15, 2017 | Sale | $15.30 | 6,000 | 91,800 | 349,305 | Sep 18, 2017, 05:46 PM | |
| ATRA | Atara Biotherapeutics, Inc. | Haqq Christopher | EVP, R&D & Chief Scientific Of | Aug 15, 2017 | Sale | $14.75 | 7,604 | 112,159 | 355,305 | Aug 17, 2017, 05:35 PM | |
| ATRA | Atara Biotherapeutics, Inc. | Haqq Christopher | EVP, R&D & Chief Scientific Of | Jul 17, 2017 | Sale | $14.92 | 6,000 | 89,520 | 362,080 | Jul 18, 2017, 04:24 PM | |
| ATRA | Atara Biotherapeutics, Inc. | Haqq Christopher | EVP, R&D & Chief Scientific Of | Jun 15, 2017 | Sale | $12.65 | 6,000 | 75,900 | 368,080 | Jun 16, 2017, 04:47 PM | |
| ATRA | Atara Biotherapeutics, Inc. | Haqq Christopher | EVP, R&D & Chief Scientific Of | May 15, 2017 | Sale | $14.99 | 7,604 | 113,984 | 374,080 | May 17, 2017, 04:58 PM | |
| ATRA | Atara Biotherapeutics, Inc. | Haqq Christopher | EVP, R&D & Chief Scientific Of | Apr 17, 2017 | Sale | $17.28 | 6,000 | 103,680 | 380,855 | Apr 19, 2017, 04:29 PM | |
| ATRA | Atara Biotherapeutics, Inc. | Haqq Christopher | EVP, R&D & Chief Scientific Of | Mar 15, 2017 | Sale | $19.60 | 6,000 | 117,600 | 386,855 | Mar 17, 2017, 05:07 PM | |
| ATRA | Atara Biotherapeutics, Inc. | Haqq Christopher | EVP, R&D & Chief Scientific Of | Feb 15, 2017 | Sale | $15.49 | 7,604 | 117,786 | 392,855 | Feb 16, 2017, 08:08 PM | |
| ATRA | Atara Biotherapeutics, Inc. | Haqq Christopher | EVP, R&D & Chief Scientific Of | Feb 09, 2017 | Sale | $15.46 | 13,975 | 216,054 | 399,630 | Feb 10, 2017, 06:23 PM | |
| ATRA | Atara Biotherapeutics, Inc. | Haqq Christopher | EVP, R&D & Chief Scientific Of | Jan 17, 2017 | Sale | $14.27 | 6,000 | 85,620 | 364,105 | Jan 18, 2017, 07:52 PM | |
| ATRA | Atara Biotherapeutics, Inc. | Haqq Christopher | Chief Medical Officer | Dec 15, 2016 | Sale | $15.40 | 6,000 | 92,400 | 370,105 | Dec 15, 2016, 07:28 PM | |
| ATRA | Atara Biotherapeutics, Inc. | Haqq Christopher | Chief Medical Officer | Nov 21, 2016 | Sale | $17.85 | 7,068 | 126,164 | 376,105 | Nov 22, 2016, 06:40 PM | |
| ATRA | Atara Biotherapeutics, Inc. | Haqq Christopher | Chief Medical Officer | Nov 15, 2016 | Sale | $19.95 | 1,604 | 32,000 | 383,173 | Nov 17, 2016, 04:53 PM | |
| ATRA | Atara Biotherapeutics, Inc. | Haqq Christopher | Chief Medical Officer | Aug 15, 2016 | Sale | $22.32 | 1,346 | 30,041 | 294,894 | Aug 17, 2016, 07:47 PM | |
| ATRA | Atara Biotherapeutics, Inc. | Haqq Christopher | Chief Medical Officer | May 16, 2016 | Sale | $15.57 | 1,605 | 24,990 | 294,465 | May 18, 2016, 07:05 PM | |
| ATRA | Atara Biotherapeutics, Inc. | Haqq Christopher | Chief Medical Officer | Feb 16, 2016 | Sale | $15.43 | 3,208 | 49,499 | 295,240 | Feb 18, 2016, 08:13 PM | |
| ATRA | Atara Biotherapeutics, Inc. | Haqq Christopher | Chief Medical Officer | Aug 31, 2015 | Sale | $41.99 | 5,000 | 209,961 | 244,790 | Sep 01, 2015, 09:40 PM | |
| ATRA | Atara Biotherapeutics, Inc. | Haqq Christopher | Chief Medical Officer | Aug 17, 2015 | Sale | $45.91 | 1,604 | 73,632 | 246,190 | Aug 19, 2015, 08:26 PM | |
| ATRA | Atara Biotherapeutics, Inc. | Haqq Christopher | Chief Medical Officer | Jul 31, 2015 | Sale | $55.43 | 2,500 | 138,575 | 246,665 | Aug 03, 2015, 05:18 PM | |
| ATRA | Atara Biotherapeutics, Inc. | Haqq Christopher | Chief Medical Officer | Jul 15, 2015 | Sale | $62.94 | 2,500 | 157,353 | 249,965 | Jul 15, 2015, 09:03 PM | |
| ATRA | Atara Biotherapeutics, Inc. | Haqq Christopher | Chief Medical Officer | Jul 01, 2015 | Sale | $51.68 | 2,500 | 129,196 | 252,965 | Jul 02, 2015, 06:18 PM | |
| ATRA | Atara Biotherapeutics, Inc. | Haqq Christopher | Chief Medical Officer | Jun 15, 2015 | Sale | $46.42 | 7,500 | 348,116 | 261,365 | Jun 16, 2015, 08:08 PM | |
| ATRA | Atara Biotherapeutics, Inc. | Haqq Christopher | Chief Medical Officer | Jun 01, 2015 | Sale | $41.47 | 2,500 | 103,665 | 262,815 | Jun 01, 2015, 05:39 PM | |
| ATRA | Atara Biotherapeutics, Inc. | Haqq Christopher | Chief Medical Officer | May 15, 2015 | Option Exercise | $37.30 | 1,887 | 70,385 | 264,165 | May 19, 2015, 06:57 PM |
Menu